Food, Drugs or Both? Metabolic Care in the GLP-1 Era
With the rapid rise of GLP-1 medications transforming obesity and metabolic care, clinicians are increasingly faced with questions about where food-based interventions fit within treatment pathways. This panel will explore how nutrition, lifestyle medicine and pharmacology can be integrated to deliver personalised, sustainable metabolic care.

.jpg.png)
